Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Dermata Therapeutics Inc (DRMA)

13 + Investors. Track Smart Money conviction in DRMA. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +6
Streak
1Q ▲
Buyers last Q
73%

Smart Money Signals — DRMA

Based on 13 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added DRMA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
13 hedge funds hold DRMA right now — the highest count in 2.2 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +30% more funds vs a year ago

fund count last 6Q
+3 new funds entered over the past year (+30% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 73% buying

8 buying3 selling
Last quarter: 8 funds were net buyers (7 opened a brand new position + 1 added to an existing one). Only 3 were sellers (2 trimmed + 1 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~7 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 0 → 3 → 4 → 7. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 69% entered in last year

15% conviction (2yr+) 15% medium 69% new
Only 2 funds (15%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
➡️

Steady discovery — ~7 new funds/quarter

3 → 0 → 3 → 4 → 7 new funds/Q
New funds entering each quarter: 0 → 3 → 4 → 7. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🌱

Early stage — 69% of holders entered in last year

0% veterans 31% 1-2yr 69% new
Of 13 current holders: 9 (69%) entered in the past year, only 0 (0%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
🏆

Elite ownership — 46% AUM from top-100 funds

46% from top-100 AUM funds
5 of 13 holders are among the 100 largest funds by AUM, controlling 46% of total institutional value in DRMA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
5.5
out of 10
Moderate Exit Risk
Exit risk score 5.5/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — DRMA

In 2026 Q2, 8 hedge funds were net buyers of DRMA (7 opened a new position, 1 added to an existing one), while 3 reduced or exited (2 trimmed, 1 sold completely) — a 73% buyer ratio, indicating clear institutional accumulation. 46% of total institutional value in DRMA is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +6 funds (more new holders than closures). Total institutional holders: 13.

Hedge Fund Ownership: DRMA

How many hedge funds hold DRMA — quarterly history vs. share price
Quarterly hedge fund ownership of DRMA vs. share price

Market Analysis: DRMA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: DRMA

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

0 top-rated funds 0 high-conviction
Consensus
0.0
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: DRMA
13 + Investors

Track Smart Money conviction in DRMA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 13 7 85.71%
13F Shares 123K 106K 15.04%
Total Value $158K $129K 22.65%
New Positions 7 4 +3
Increased Positions 1 1 -
Closed Positions 1 4 -3
Reduced Positions 2 1 +1
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: DRMA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

13 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in DRMA. Verified SEC 13F-HR filings.

QUARTER:
Top 11 DRMA holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Advisory Alpha, LLC 0.00% 10,000 $13K
2 Welch & Forbes LLC 0.00% 20,000 $26K
3 XTX Topco Ltd 0.00% 14,787 $19K
4 Tower Research Capital LLC (TRC) 0.00% 3,860 $5K
5 MCF Advisors LLC 0.00% 1,732 $2K
6 Highline Wealth Partners LLC 0.00% 26
7 SBI Securities Co., Ltd. 0.00% 101
8 UBS Group AG 0.00% 16,796 $22K
9 Susquehanna International Group, LLP 0.00% 15,989 $21K
10 Barclays plc 0.00% 270
11 Morgan Stanley 0.00% 2
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Dermata Therapeutics Inc (DRMA)

What does the Smart Money Trend signal show for DRMA?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added DRMA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for DRMA?

More buyers than sellers — 73% buying: Last quarter: 8 funds were net buyers (7 opened a brand new position + 1 added to an existing one). Only 3 were sellers (2 trimmed + 1 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for DRMA holders?

Elite ownership — 46% AUM from top-100 funds: 5 of 13 holders are among the 100 largest funds by AUM, controlling 46% of total institutional value in DRMA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held DRMA?

Mostly new holders — 69% entered in last year: Only 2 funds (15%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →